CLINICAL_TRIALS
trial_result
· 2016-02-05
Clinical Trial Update: A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics [Phase 3]
Summary
A Phase 3 study evaluating chronic-dose safety and efficacy of a multi-dose dry powder albuterol inhaler in pediatric asthma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2016-02-05